SEC Investigates Par Pharmaceutical
The U.S. Securities and Exchange Commission is investigating Par Pharmaceutical Companies Inc. following the company's July 5 announcement that it will restate its financial results for the fiscal years 2004 and...To view the full article, register now.
Already a subscriber? Click here to view full article